Suzuken Co., Ltd. (FRA:ZU1)

Market Cap	1.83B -21.9%
Revenue (ttm)	13.56B +3.6%
Net Income	208.01M +10.6%
EPS	2.98 +20.0%
Shares Out	n/a
PE Ratio	8.78
Forward PE	n/a
Dividend	50.27 (190.42%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	26.40
Previous Close	26.60
Day's Range	26.40 - 26.40
52-Week Range	25.80 - 35.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplie...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1932
• Employees: 12,923
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ZU1

Financial Performance

In fiscal year 2026, Suzuken's revenue was 2.49 trillion, an increase of 3.61% compared to the previous year's 2.40 trillion. Earnings were 38.14 billion, an increase of 10.55%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error